An increasing AST/ALT ratio is associated with declining glucose regulation, metabolic impairment, and organ dysfunction, including non-alcoholic fatty liver disease and cardiovascular disease [52]. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.